These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 33809747)

  • 1. Development and Validation of 2-Azaspiro [4,5] Decan-3-One (Impurity A) in Gabapentin Determination Method Using qNMR Spectroscopy.
    Kuz'mina NE; Moiseev SV; Khorolskiy MD; Lutceva AI
    Molecules; 2021 Mar; 26(6):. PubMed ID: 33809747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and application of a validated HPLC method for the determination of gabapentin and its major degradation impurity in drug products.
    Ciavarella AB; Gupta A; Sayeed VA; Khan MA; Faustino PJ
    J Pharm Biomed Anal; 2007 Apr; 43(5):1647-53. PubMed ID: 17275240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly sensitive determination and validation of gabapentin in pharmaceutical preparations by HPLC with 4-fluoro-7-nitrobenzofurazan derivatization and fluorescence detection.
    Ulu ST; Kel E
    J Chromatogr Sci; 2011; 49(6):417-21. PubMed ID: 21682989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a purity control strategy for pemetrexed disodium and validation of associated analytical methodology.
    Warner A; Piraner I; Weimer H; White K
    J Pharm Biomed Anal; 2015 Feb; 105():46-54. PubMed ID: 25527981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and application of a validated HPLC method for the analysis of dissolution samples of gabapentin drug products.
    Gupta A; Ciavarella AB; Sayeed VA; Khan MA; Faustino PJ
    J Pharm Biomed Anal; 2008 Jan; 46(1):181-6. PubMed ID: 17935923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous determination of the component ratio and moisture content in TEGDN/NG composites by the qNMR method.
    Liu K; Wang M; Zhang G; Meng Z
    Anal Methods; 2022 Aug; 14(33):3203-3208. PubMed ID: 35943237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Application of Quantitative ¹H-NMR for the Determination of Orlistat in Tablets.
    Sun S; Jin M; Zhou X; Ni J; Jin X; Liu H; Wang Y
    Molecules; 2017 Sep; 22(9):. PubMed ID: 28891958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative determination and validation of avermectin B1a in commercial products using quantitative nuclear magnetic resonance spectroscopy.
    Hou Z; Liang X; Du L; Su F; Su W
    Magn Reson Chem; 2014 Sep; 52(9):480-5. PubMed ID: 24943110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UHPLC-fluorescence method for the determination of trace levels of hydrazine in allopurinol and its formulations: Validation using total-error concept.
    Christofi M; Markopoulou CK; Tzanavaras PD; Zacharis CK
    J Pharm Biomed Anal; 2020 Aug; 187():113354. PubMed ID: 32416339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous relative UV response determination of known liquid drug product degradants by NMR spectroscopy.
    Samuels ER; Wang T
    J Pharm Biomed Anal; 2022 May; 213():114665. PubMed ID: 35217258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative
    Duangdee N; Chamboonchu N; Kongkiatpaiboon S; Prateeptongkum S
    Phytochem Anal; 2019 Nov; 30(6):617-622. PubMed ID: 31020748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of azide impurity in sartans using reversed-phase HPLC with UV detection.
    Gričar M; Andrenšek S
    J Pharm Biomed Anal; 2016 Jun; 125():27-32. PubMed ID: 26999319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a HPLC method for 4,7-phenanthroline-5,6-dione I and identification of its major impurity by HPLC-MS-APCI.
    Shabir GA; Forrow NJ
    J Chromatogr Sci; 2005 Apr; 43(4):207-12. PubMed ID: 15975237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification, Characterization, Synthesis and Quantification of Related Impurities of Liguzinediol.
    Cheng D; Zhou Y; Li W; Shan CX; Chai C; Cui XB; Kang B; Wang TL; Wen HM
    J Chromatogr Sci; 2015 Sep; 53(8):1280-8. PubMed ID: 25680683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a reversed-phase HPLC method for simultaneous analysis of butylhydroxyanisol, simvastatin and its impurities in tablet dosage forms.
    El Karbane M; Azougagh M; Amood A L-Kamarany M; Bouchafra H; Cherrah Y; Bouklouze A
    Ann Pharm Fr; 2014 Jul; 72(4):244-55. PubMed ID: 24997886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The application of qNMR for the determination of rosuvastatin in tablet form.
    Dİkmen G; Uslu O
    Turk J Chem; 2021; 45(1):132-142. PubMed ID: 33679159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of analytical quality by design principles for the determination of alkyl p-toluenesulfonates impurities in Aprepitant by HPLC. Validation using total-error concept.
    Zacharis CK; Vastardi E
    J Pharm Biomed Anal; 2018 Feb; 150():152-161. PubMed ID: 29245084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation, structure characterization and quantification of related impurities in asperosaponin VI.
    Ji D; Liu YF; Wang QH; Zhang CF; Yang ZL
    Chin J Nat Med; 2013 Jul; 11(4):419-26. PubMed ID: 23845554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of HPLC method for the determination of Cyclosporin A and its impurities in Neoral capsules and its generic versions.
    Bonifacio FN; Giocanti M; Reynier JP; Lacarelle B; Nicolay A
    J Pharm Biomed Anal; 2009 Feb; 49(2):540-6. PubMed ID: 19124213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative determination of potential genotoxic impurity 3-aminopyridine in linagliptin active pharmaceutical ingredient using HILIC-UV.
    Al-Sabti B; Harbali J
    Biomed Chromatogr; 2020 Nov; 34(11):e4930. PubMed ID: 32579716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.